Homo sapiens Protein: GHR
Summary
InnateDB Protein IDBP-18932.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol GHR
Protein Name growth hormone receptor
Synonyms GHBP;
Species Homo sapiens
Ensembl Protein ENSP00000230882
InnateDB Gene IDBG-18930 (GHR)
Protein Structure
UniProt Annotation
Function Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity). {ECO:0000250}.The soluble form (GHBP) acts as a reservoir of growth hormone in plasma and may be a modulator/inhibitor of GH signaling.Isoform 2 up-regulates the production of GHBP and acts as a negative inhibitor of GH signaling.
Subcellular Localization Cell membrane; Single-pass type I membrane protein. Note=On growth hormone binding, GHR is ubiquitinated, internalized, down-regulated and transported into a degradative or non-degradative pathway. {ECO:0000250}.Isoform 2: Cell membrane; Single-pass type I membrane protein. Note=Remains fixed to the cell membrane and is not internalized.Growth hormone-binding protein: Secreted. Note=Complexed to a substantial fraction of circulating GH. {ECO:0000250}.
Disease Associations Laron syndrome (LARS) [MIM:262500]: A severe form of growth hormone insensitivity characterized by growth impairment, short stature, dysfunctional growth hormone receptor, and failure to generate insulin-like growth factor I in response to growth hormone. {ECO:0000269PubMed:10870033, ECO:0000269PubMed:14678285, ECO:0000269PubMed:2779634, ECO:0000269PubMed:8137822, ECO:0000269PubMed:8421103, ECO:0000269PubMed:8504296, ECO:0000269PubMed:9024232, ECO:0000269PubMed:9661642, ECO:0000269PubMed:9851797}. Note=The disease is caused by mutations affecting the gene represented in this entry.Short stature, idiopathic, autosomal (ISSA) [MIM:604271]: A condition defined by a standing height more than 2 standard deviations below the mean (or below the 2.5 percentile) for sex and chronological age, compared with a well-nourished, genetically relevant population, in the absence of specific causative disorders. {ECO:0000269PubMed:7565946}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Expressed in various tissues with high expression in liver and skeletal muscle. Isoform 4 is predominantly expressed in kidney, bladder, adrenal gland and brain stem. Isoform 1 expression in placenta is predominant in chorion and decidua. Isoform 4 is highly expressed in placental villi. Isoform 2 is expressed in lung, stomach and muscle. Low levels in liver.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 57 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 57 [view]
Protein-Protein 57 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0017046 peptide hormone binding
GO:0019838 growth factor binding
GO:0019901 protein kinase binding
GO:0042803 protein homodimerization activity
GO:0070064 proline-rich region binding
Biological Process
GO:0000187 activation of MAPK activity
GO:0000255 allantoin metabolic process
GO:0006101 citrate metabolic process
GO:0006103 2-oxoglutarate metabolic process
GO:0006105 succinate metabolic process
GO:0006107 oxaloacetate metabolic process
GO:0006549 isoleucine metabolic process
GO:0006573 valine metabolic process
GO:0006600 creatine metabolic process
GO:0006631 fatty acid metabolic process
GO:0006897 endocytosis
GO:0007259 JAK-STAT cascade
GO:0019221 cytokine-mediated signaling pathway
GO:0019530 taurine metabolic process
GO:0031623 receptor internalization
GO:0032355 response to estradiol
GO:0032870 cellular response to hormone stimulus
GO:0040014 regulation of multicellular organism growth
GO:0040018 positive regulation of multicellular organism growth
GO:0042517 positive regulation of tyrosine phosphorylation of Stat3 protein
GO:0042523 positive regulation of tyrosine phosphorylation of Stat5 protein
GO:0042977 activation of JAK2 kinase activity
GO:0044236 multicellular organismal metabolic process
GO:0046449 creatinine metabolic process
GO:0046898 response to cycloheximide
GO:0048009 insulin-like growth factor receptor signaling pathway
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0060396 growth hormone receptor signaling pathway
GO:0060397 JAK-STAT cascade involved in growth hormone signaling pathway
Cellular Component
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0009986 cell surface
GO:0016021 integral component of membrane
GO:0043235 receptor complex
GO:0070195 growth hormone receptor complex
Protein Structure and Domains
PDB ID
InterPro IPR003961 Fibronectin, type III
IPR015152 Growth hormone/erythropoietin receptor, ligand binding
PFAM PF00041
PF01108
PF09067
PRINTS
PIRSF
SMART SM00060
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P10912
PhosphoSite PhosphoSite-P10912
TrEMBL Q9NRZ8
UniProt Splice Variant
Entrez Gene 2690
UniGene Hs.714143
RefSeq NP_000154
HUGO HGNC:4263
OMIM 600946
CCDS CCDS3940
HPRD 02971
IMGT
EMBL AC093225 AC113368 AC114941 AC116343 AF155912 AJ278681 AJ295613 M28458 M28459 M28460 M28461 M28462 M28463 M28464 M28465 M28466 X06562
GenPept AAA52555 AAF71399 CAA29808 CAC06613 CAC06615